Key points are not available for this paper at this time.
It is recommended to check for BRCA1/2 mutations in all high-risk breast carcinoma patients in the Turkish population.
Geredeli et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: